Holen Sie sich die Stockscreener-App
50.22
1.60%
0.79
Handel nachbörslich:
50.35
0.13
+0.26%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DD?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$49.43
Offen:
$49.42
24-Stunden-Volumen:
4.24M
Relative Volume:
0.82
Marktkapitalisierung:
$20.55B
Einnahmen:
$12.61B
Nettoeinkommen (Verlust:
$109.00M
KGV:
-107.61
EPS:
-0.4667
Netto-Cashflow:
$1.32B
1W Leistung:
+7.47%
1M Leistung:
+14.68%
6M Leistung:
-32.13%
1J Leistung:
-40.25%
1-Tages-Spanne:
$48.90
$50.30
1-Wochen-Bereich:
$46.33
$52.66
52-Wochen-Spanne:
$33.34
$85.00
Dupont De Nemours Inc Stock (DD) Company Profile
Firmenname
Dupont De Nemours Inc
Sektor
Branche
Telefon
(302) 295-5783
Adresse
974 CENTRE ROAD, WILMINGTON, DE
Compare DD vs LIN, SHW, ECL, APD, PPG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DD
Dupont De Nemours Inc
|
50.22 | 20.23B | 12.61B | 109.00M | 1.32B | -0.4667 |
|
LIN
Linde plc Ordinary Share
|
481.00 | 220.80B | 33.99B | 7.06B | 5.06B | 14.59 |
|
SHW
Sherwin Williams Co
|
368.89 | 92.37B | 23.57B | 2.57B | 2.43B | 10.26 |
|
ECL
Ecolab Inc
|
299.17 | 85.17B | 16.08B | 2.09B | 1.55B | 7.2773 |
|
APD
Air Products Chemicals Inc
|
279.74 | 64.90B | 12.21B | -304.80M | -2.81B | -1.5006 |
|
PPG
Ppg Industries Inc
|
131.34 | 29.52B | 15.88B | 1.59B | 725.00M | 6.9113 |
Dupont De Nemours Inc Stock (DD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-03 | Bestätigt | Citigroup | Buy |
| 2025-04-15 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2025-04-14 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-02-13 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2025-01-17 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2024-10-07 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2024-05-28 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-05-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-05-23 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2024-05-17 | Hochstufung | Jefferies | Hold → Buy |
| 2024-03-01 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-01-24 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2024-01-24 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-01-16 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-07-19 | Bestätigt | Citigroup | Neutral |
| 2023-06-14 | Eingeleitet | Citigroup | Neutral |
| 2023-05-15 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2023-01-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-01-12 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-12-20 | Fortgesetzt | JP Morgan | Overweight |
| 2022-06-16 | Herabstufung | Jefferies | Buy → Hold |
| 2022-02-09 | Bestätigt | Barclays | Equal Weight |
| 2022-02-09 | Bestätigt | BofA Securities | Buy |
| 2022-02-09 | Bestätigt | Citigroup | Buy |
| 2022-02-09 | Bestätigt | Deutsche Bank | Buy |
| 2022-02-09 | Bestätigt | Mizuho | Buy |
| 2021-11-03 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-11-03 | Hochstufung | Vertical Research | Hold → Buy |
| 2021-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-10-04 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-07-06 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-05-26 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-05-11 | Hochstufung | Goldman | Neutral → Buy |
| 2021-03-22 | Eingeleitet | Barclays | Equal Weight |
| 2021-02-11 | Hochstufung | DZ Bank | Sell → Hold |
| 2021-02-03 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-01-28 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-01-27 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-01-21 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-01-14 | Herabstufung | DZ Bank | Buy → Sell |
| 2021-01-14 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-01-13 | Herabstufung | HSBC Securities | Buy → Hold |
| 2021-01-13 | Herabstufung | Vertical Research | Buy → Hold |
| 2020-08-03 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-06-25 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-06-19 | Bestätigt | Wells Fargo | Overweight |
| 2020-04-29 | Fortgesetzt | Wells Fargo | Overweight |
| 2020-04-20 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-03-26 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-01-14 | Eingeleitet | Gordon Haskett | Buy |
| 2020-01-06 | Eingeleitet | JP Morgan | Neutral |
| 2019-12-17 | Bestätigt | Cowen | Outperform |
| 2019-11-15 | Bestätigt | Cowen | Outperform |
| 2019-09-10 | Eingeleitet | Jefferies | Buy |
| 2019-08-30 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2019-08-20 | Bestätigt | Cowen | Outperform |
| 2019-06-25 | Fortgesetzt | Monness Crespi & Hardt | Neutral |
| 2019-06-10 | Eingeleitet | Cowen | Outperform |
Alle ansehen
Dupont De Nemours Inc Aktie (DD) Neueste Nachrichten
Will DuPont de Nemours Inc. benefit from sector rotationJuly 2025 Opening Moves & Weekly High Return Opportunities - mfd.ru
DuPont targets 3% organic sales growth and $2.25–$2.30 EPS for 2026 as portfolio transformation accelerates - MSN
Mold Inhibitors Market Size to be Valued at USD 2.20 Billion by 2033 Owing to the Surging Demand for Natural and Clean-Label Preservatives Among Applications Globally - GlobeNewswire Inc.
DuPont (DD) Receives Rating Update from BMO Capital | DD Stock N - GuruFocus
DuPont Named Finalist in 2026 Edison Awards for FilmTec Fortilife XC160UHP Membrane for Wastewater Treatment and Reuse - Finviz
DuPont de Nemours Inc (DD)'s Uncertain Future: Understanding the Barriers to Outperformance - GuruFocus
BMO Capital raises DuPont stock price target to $60 on healthcare growth By Investing.com - Investing.com India
DuPont Stock Fell 31% Over the Past Year. Do Analysts See a Recovery to $62 in 2026? - TIKR.com
BMO Capital raises DuPont stock price target to $60 on healthcare growth - Investing.com
DuPont Named Finalist in 2026 Edison Awards for FilmTec™ Fortilife™ XC160UHP Membrane for Wastewater Treatment and Reuse - marketscreener.com
New DuPont membrane turns factory wastewater into reusable water - Stock Titan
Should I average down on DuPont de Nemours Inc. stockJuly 2025 Intraday Action & Community Shared Stock Ideas - mfd.ru
DuPont Earnings Call Shows Profits Rising Amid Headwinds - The Globe and Mail
DuPont de Nemours (DD) Receives Updated 'Buy' Rating and Price T - GuruFocus
DuPont (DD) Receives Price Target Boost from Jefferies | DD Stoc - GuruFocus
DuPont de Nemours (DD) Rating Maintained by UBS, Price Target Ra - GuruFocus
DD: Wells Fargo Raises DuPont de Nemours Price Target to $55 | D - GuruFocus
DuPont de Nemours Likely to Benefit From Favorable Water, Health Care Market Trends, Morgan Stanley Says - marketscreener.com
Keybanc Raises DuPont (DD) Price Target to $57, Maintains Overwe - GuruFocus
Jefferies Adjusts Price Target on DuPont de Nemours to $59 From $51, Maintains Buy Rating - marketscreener.com
KeyBanc Adjusts Price Target on DuPont de Nemours to $57 From $51, Maintains Overweight Rating - marketscreener.com
DuPont stock price target raised to $57 from $51 at KeyBanc - Investing.com
The Analyst Verdict: DuPont de Nemours In The Eyes Of 7 Experts - Benzinga
DuPont de Nemours, Inc. (NYSE:DD) Q4 2025 earnings call transcript - MSN
DuPont de Nemours, Inc. (NYSE:DD) Q4 2025 Earnings Call Transcript - Insider Monkey
Morgan Stanley Raises Price Target on DuPont de Nemours to $52 From $44, Keeps Equalweight Rating - marketscreener.com
Flame Resistant Clothing Market Is Going to Boom | DuPont de - openPR.com
Ultrafiltration Membrane Market Is Going to Boom | DuPont de Nemours, Inc., Toray Industries, Inc. - openPR.com
Smart Textile Market Booming with Rapid Growth Through 2033 | DuPont de Nemours, Inc., Toray Industries, Inc. - openPR.com
Is It Too Late To Consider DuPont De Nemours (DD) After Strong Multi‑Year Share Gains? - Yahoo Finance
DuPont de Nemours Q4 Earnings Call Highlights - Yahoo Finance
DuPont Q4 2025 slides reveal margin expansion, healthcare strength amid construction weakness - Investing.com Nigeria
DuPont Q4: Leaner Operations Are Positive, But Growth Is Unimpressive (NYSE:DD) - Seeking Alpha
DuPont’s Earnings Boost the Stock to 52-Week High. Here’s Why. - Barron's
DuPont de Nemours Inc (DD) Q4 2025 Earnings Call Highlights: Strong Financial Performance and ... By GuruFocus - Investing.com Canada
DuPont Reports 2025 Full-Year Results and Issues 2026 Guidance Following Strategic Spinoffs - AlphaStreet News
DuPont Earnings Boost Stock to 52-Week High. Here’s Why. - Barron's
DuPont de Nemours Inc (DD) Q4 2025 Earnings Call Highlights: Strong Financial Performance and Strategic Initiatives - GuruFocus
DuPont (DD) Reports Strong Q4 and Sets Positive 2026 Outlook - GuruFocus
Jim Cramer on DuPont's Lori Koch: "She's Done a Terrific Job" - Finviz
DuPont Reports Strong Q4 2025 Earnings with Strategic Growth Focus - Intellectia AI
DuPont Reinvents Itself: Strategic Pivot Drives Earnings Beat and Bullish 2026 Outlook - FinancialContent
Why Is DuPont Stock Gaining Tuesday?DuPont de Nemours (NYSE:DD) - Benzinga
Jim Cramer on DuPont’s Lori Koch: “She’s done a terrific job” - MSN
DuPont Tops Earnings Estimates in Q4, Reports Flat Y/Y Sales - Yahoo Finance
Jim Cramer on DuPont’s Lori Koch: “She’s Done a Terrific Job” - Insider Monkey
DuPont Should Benefit From Long-Term Growing Demand for Healthcare and Water Filtration - Morningstar
DuPont Stock Pops After Earnings Beat. ‘Strong’ Quarter Bolsters Market Hopes. - Barron's
DuPont tops fourth-quarter estimates, shares climb premarket (DD:NYSE) - Seeking Alpha
DuPont edges past Q4 profit forecasts and sets guidance for the year ahead - MSN
DuPont (DD) Provides 2026 Revenue and EBITDA Forecast - GuruFocus
Finanzdaten der Dupont De Nemours Inc-Aktie (DD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.14%
0.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):